Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Viking Thera (VKTX)

Viking Thera (VKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,919,316
  • Shares Outstanding, K 110,268
  • Annual Sales, $ 0 K
  • Annual Income, $ -85,900 K
  • 60-Month Beta 1.12
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 7.41
Trade VKTX with:

Options Overview Details

View History
  • Implied Volatility 89.31% ( +0.51%)
  • Historical Volatility 65.46%
  • IV Percentile 37%
  • IV Rank 38.00%
  • IV High 234.70% on 02/16/24
  • IV Low 0.20% on 02/27/24
  • Put/Call Vol Ratio 0.16
  • Today's Volume 14,471
  • Volume Avg (30-Day) 19,752
  • Put/Call OI Ratio 0.29
  • Today's Open Interest 170,904
  • Open Int (30-Day) 173,092

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.25
  • Number of Estimates 8
  • High Estimate -0.17
  • Low Estimate -0.31
  • Prior Year -0.19
  • Growth Rate Est. (year over year) -31.58%

Price Performance

See More
Period Period Low Period High Performance
1-Month
61.09 +6.99%
on 05/23/24
81.86 -20.16%
on 05/07/24
-8.95 (-12.04%)
since 04/26/24
3-Month
60.30 +8.39%
on 03/18/24
96.74 -32.44%
on 03/06/24
-29.14 (-30.84%)
since 02/28/24
52-Week
8.28 +689.37%
on 10/26/23
99.41 -34.25%
on 02/28/24
+44.05 (+206.71%)
since 05/26/23

Most Recent Stories

More News
If You'd Invested $100 in Viking Therapeutics Stock 2 Years Ago, Here's How Much You'd Have Today

What would a $100 investment in Viking Therapeutics back in 2022 be worth today? Prepare to be surprised.

GS : 459.81 (-0.30%)
RHHBY : 31.3000 (-0.95%)
VKTX : 65.36 (+4.16%)
Where Will Viking Therapeutics Be in 5 Years?

Could Viking Therapeutics become a big player in the GLP-1 drug market?

VKTX : 65.36 (+4.16%)
2 Stocks That Could 10x by 2035

These stocks are very promising, but it's important to consider the downside, too.

LLY : 807.86 (+0.05%)
VKTX : 65.36 (+4.16%)
RXRX : 8.99 (-1.86%)
5 Breakout Biotech Stocks Leading the Russell 2000 Higher

These small-cap biotech stocks are rallying hard in 2024, and still have room to keep leading the RUT higher.

JANX : 47.26 (+4.17%)
VKTX : 65.36 (+4.16%)
LBPH : 18.66 (-0.74%)
ARQT : 8.88 (-3.06%)
RNA : 26.32 (-4.12%)
Is It Too Late to Buy Viking Therapeutics Stock?

This rising star probably won't burn out soon.

VKTX : 65.36 (+4.16%)
3 Monster Stocks in the Making You Can Buy Right Now

These stocks might not be small for too much longer.

GS : 459.81 (-0.30%)
LLY : 807.86 (+0.05%)
ALT : 6.97 (-4.91%)
AXSM : 76.76 (+2.09%)
VKTX : 65.36 (+4.16%)
Is Viking Therapeutics Stock a Buy?

The stock could have room to soar higher if VK2735 obtains approval from regulators.

VKTX : 65.36 (+4.16%)
How Viking Therapeutics Stock Could 30x

This mid-cap biopharma may one day be a titan of the industry.

LLY : 807.86 (+0.05%)
NVO : 134.08 (-1.44%)
VKTX : 65.36 (+4.16%)
PFE : 28.30 (-2.01%)
Is Viking Therapeutics the Best Biotech Stock for You?

With good mid-stage results and plenty of cash, Viking could be a winner.

VKTX : 65.36 (+4.16%)
Eli Lilly Raised Its Outlook. Is the Stock a Buy Now?

The anti-obesity medication stock is way up, and there could be more fuel in the tank.

NVO : 134.08 (-1.44%)
VKTX : 65.36 (+4.16%)
LLY : 807.86 (+0.05%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Viking Therapeutics, Inc. is a biopharmaceutical company. The company is engaged in development of novel therapies for metabolic and endocrine disorders. Its product candidate consists of VK5211, VK0214, VK0612 and VK2809 which are in different clinical trial. Viking Therapeutics, Inc. is based in LA...

See More

Key Turning Points

3rd Resistance Point 70.30
2nd Resistance Point 68.10
1st Resistance Point 66.73
Last Price 65.36
1st Support Level 63.16
2nd Support Level 60.96
3rd Support Level 59.59

See More

52-Week High 99.41
Last Price 65.36
Fibonacci 61.8% 64.60
Fibonacci 50% 53.85
Fibonacci 38.2% 43.09
52-Week Low 8.28

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar